185 related articles for article (PubMed ID: 22091248)
1. Effect of soy phytoestrogen on metabolic and hormonal disturbance of women with polycystic ovary syndrome.
Khani B; Mehrabian F; Khalesi E; Eshraghi A
J Res Med Sci; 2011 Mar; 16(3):297-302. PubMed ID: 22091248
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
Falsetti L; Pasinetti E
Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
4. Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study.
Romualdi D; Costantini B; Campagna G; Lanzone A; Guido M
Fertil Steril; 2008 Nov; 90(5):1826-33. PubMed ID: 18166189
[TBL] [Abstract][Full Text] [Related]
5. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Clinical, Metabolic and Hormonal Effects of Metformin Versus Combined Therapy of Metformin With Myoinositol Plus D-Chiro-Inositol in Women With Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial.
Bahadur A; Arora H; Ravi AK; Naithani M; Bahurupi Y; Chaturvedi J; Ajmani M; Mundhra R
Cureus; 2021 Jun; 13(6):e15510. PubMed ID: 34268040
[TBL] [Abstract][Full Text] [Related]
7. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
Deswal R; Nanda S; Dang AS
Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
[TBL] [Abstract][Full Text] [Related]
8. Estrogenic properties of genistein acting on FSHR and LHR in rats with PCOS.
Zhang T; Chi XX
Pol J Vet Sci; 2019 Mar; 22(1):83-90. PubMed ID: 30997768
[TBL] [Abstract][Full Text] [Related]
9. [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
Chen Y; Wang XJ; Jin HL; Jin L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):751-6. PubMed ID: 23980352
[TBL] [Abstract][Full Text] [Related]
10. Effect of chamomile capsule on lipid- and hormonal-related parameters among women of reproductive age with polycystic ovary syndrome.
Heidary M; Yazdanpanahi Z; Dabbaghmanesh MH; Parsanezhad ME; Emamghoreishi M; Akbarzadeh M
J Res Med Sci; 2018; 23():33. PubMed ID: 29887901
[TBL] [Abstract][Full Text] [Related]
11. Plasma selenium levels in Turkish women with polycystic ovary syndrome.
Coskun A; Arikan T; Kilinc M; Arikan DC; Ekerbiçer HÇ
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):183-6. PubMed ID: 23490536
[TBL] [Abstract][Full Text] [Related]
12. Clinical and hormonal features of women with polycystic ovary syndrome living in rural and urban areas.
Katulski K; Czyzyk A; Podkowa N; Podfigurna-Stopa A; Ignaszak N; Paczkowska K; Slawek S; Szpurek D; Meczekalski B
Ann Agric Environ Med; 2017 Sep; 24(3):522-526. PubMed ID: 28954502
[TBL] [Abstract][Full Text] [Related]
13. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women.
Sanke S; Chander R; Jain A; Garg T; Yadav P
JAMA Dermatol; 2016 Sep; 152(9):986-91. PubMed ID: 27304785
[TBL] [Abstract][Full Text] [Related]
14. Correlation analysis of myonectin levels with metabolic and hormonal disorders in patients with polycystic ovary syndrome.
Zhang J; Chen L; Ye J
Ann Palliat Med; 2021 Mar; 10(3):3404-3409. PubMed ID: 33752430
[TBL] [Abstract][Full Text] [Related]
15. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
16. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA
Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
[TBL] [Abstract][Full Text] [Related]
17. Are progranulin levels associated with polycystic ovary syndrome and its possible metabolic effects in adolescents and young women?
Ersoy AO; Tokmak A; Ozler S; Oztas E; Ersoy E; Celik HT; Erdamar H; Yilmaz N
Arch Gynecol Obstet; 2016 Aug; 294(2):403-9. PubMed ID: 27071619
[TBL] [Abstract][Full Text] [Related]
18. Is serum leptin level regulated by thyroid functions, lipid metabolism and insulin resistance in polycystic ovary syndrome?
Erel CT; Senturk LM; Kaleli S; Gezer A; Baysal B; Tasan E
Gynecol Endocrinol; 2003 Jun; 17(3):223-9. PubMed ID: 12857430
[TBL] [Abstract][Full Text] [Related]
19. [Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome].
Hu WH; Qiao J; Zhao SY; Zhang XW; Li MZ
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):487-91. PubMed ID: 17068620
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and Endocrine Characteristics of Indian Women with Polycystic Ovary Syndrome.
Kumar AN; Naidu JN; Satyanarayana U; Ramalingam K; Anitha M
Int J Fertil Steril; 2016; 10(1):22-8. PubMed ID: 27123196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
